1. Home
  2. ACOG vs UFI Comparison

ACOG vs UFI Comparison

Compare ACOG & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • UFI
  • Stock Information
  • Founded
  • ACOG 2000
  • UFI 1969
  • Country
  • ACOG Canada
  • UFI United States
  • Employees
  • ACOG N/A
  • UFI N/A
  • Industry
  • ACOG
  • UFI Textiles
  • Sector
  • ACOG
  • UFI Consumer Discretionary
  • Exchange
  • ACOG Nasdaq
  • UFI Nasdaq
  • Market Cap
  • ACOG 80.3M
  • UFI 91.3M
  • IPO Year
  • ACOG N/A
  • UFI N/A
  • Fundamental
  • Price
  • ACOG $10.35
  • UFI $4.76
  • Analyst Decision
  • ACOG Strong Buy
  • UFI
  • Analyst Count
  • ACOG 1
  • UFI 0
  • Target Price
  • ACOG $20.00
  • UFI N/A
  • AVG Volume (30 Days)
  • ACOG 62.9K
  • UFI 41.9K
  • Earning Date
  • ACOG 08-14-2025
  • UFI 08-20-2025
  • Dividend Yield
  • ACOG N/A
  • UFI N/A
  • EPS Growth
  • ACOG N/A
  • UFI N/A
  • EPS
  • ACOG N/A
  • UFI N/A
  • Revenue
  • ACOG $2,928,654.00
  • UFI $590,261,000.00
  • Revenue This Year
  • ACOG N/A
  • UFI $1.08
  • Revenue Next Year
  • ACOG N/A
  • UFI $9.96
  • P/E Ratio
  • ACOG N/A
  • UFI N/A
  • Revenue Growth
  • ACOG N/A
  • UFI 2.51
  • 52 Week Low
  • ACOG $3.75
  • UFI $4.25
  • 52 Week High
  • ACOG $11.54
  • UFI $7.91
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • UFI 45.51
  • Support Level
  • ACOG N/A
  • UFI $4.77
  • Resistance Level
  • ACOG N/A
  • UFI $4.98
  • Average True Range (ATR)
  • ACOG 0.00
  • UFI 0.16
  • MACD
  • ACOG 0.00
  • UFI -0.02
  • Stochastic Oscillator
  • ACOG 0.00
  • UFI 18.87

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

Share on Social Networks: